Morgan L. Maeder, et al. Therapeutic Correction of an LCA-Causing Splice Defect in the CEP290 Gene by CRISPR/Cas-Mediated Genome Editing. Presented at the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016 in Seattle, WA.

Jan

11

Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference

Jan

11

Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial

Jan

11

Editas Medicine Announces Transition of Chief Scientific Officer